Botanical research centers
This article was originally published in The Tan Sheet
NCCAM and NIH's Office of Dietary Supplements are co-funding five-year grants for five research centers investigating "a variety of widely consumed botanicals from flaxseed to tarragon," NCCAM Director Stephen Straus, MD, announces April 7. The Memorial Sloan-Kettering Cancer Center in New York will research botanicals that may modulate immune function, including echinacea and Chinese herbal formulations. Metabolic syndrome, obesity and diabetes are the focus of a partnership between Rutgers and Louisiana State University. Other study areas include anti-inflammatory actions of botanical lipids at Wake Forest and Harvard; women's health at the University of Illinois-Chicago; and age-related diseases at Purdue, Rutgers and the University of Alabama. First-year funding for all five combined totals about $6.75 mil...
You may also be interested in...
The company has identified 600 sites of care to treat Alzheimer's patients with aducanumab in the US and is confident on its pricing strategy, management said.
The robotic surgery company recorded $1.29bn in first-quarter revenue, an 18% year-over-year increase. Worldwide da Vinci procedures were up 16% as surgical volumes recovered from the pandemic.
The Department of Toxic Substances Control does not identify specific chemicals of concern in its 2021-2023 Priority Product Draft Work Plan, but says it is focusing on ingredients and endpoints associated with children, women of childbearing age, communities of color and aquatic impacts.